These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2810428)
1. The acute effects of ligustrazini on hemodynamics and right cardiac function in pulmonary arterial hypertension secondary to chronic obstructive pulmonary disease. Peng W; Duan SF J Tongji Med Univ; 1989; 9(2):100-2. PubMed ID: 2810428 [TBL] [Abstract][Full Text] [Related]
2. Contrasting acute effects of vasodilators (nitroglycerin, nitroprusside, and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hypertension: a combined radionuclide-hemodynamic study. Brent BN; Berger HJ; Matthay RA; Mahler D; Pytlik L; Zaret BL Am J Cardiol; 1983 Jun; 51(10):1682-9. PubMed ID: 6407295 [TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the immediate effect of ligustrazine in chronic cor pulmonale]. Peng W; Duan SF Zhonghua Nei Ke Za Zhi; 1989 Feb; 28(2):93-4, 126-7. PubMed ID: 2737042 [TBL] [Abstract][Full Text] [Related]
4. Hemodynamic and hemorrheologic effect of ligustrazini in chronic obstructive pulmonary disease with cor pulmonale. Peng W; Duan SF Chin Med J (Engl); 1987 Dec; 100(12):965-70. PubMed ID: 3133172 [No Abstract] [Full Text] [Related]
5. [Effect of captopril on pulmonary arterial hypertension in congestive heart failure associated with chronic obstructive bronchopneumopathy]. Saadjian A; Philip-Joet F; Allard-Latour G; Arnaud A; Torresani J Rev Pneumol Clin; 1984; 40(5):321-5. PubMed ID: 6395282 [TBL] [Abstract][Full Text] [Related]
6. The effects of hydralazine on exercise capacity in pulmonary hypertension secondary to chronic obstructive pulmonary disease. Dal Nogare AR; Rubin LJ Am Rev Respir Dis; 1986 Mar; 133(3):385-9. PubMed ID: 3954247 [TBL] [Abstract][Full Text] [Related]
7. [Hemodynamic and respiratory effects of phentolamine in pulmonary hypertension secondary to chronic obstructive syndrome]. Domenighetti G; Leuenberger P; Perret C Schweiz Med Wochenschr; 1985 Jan; 115(3):99-103. PubMed ID: 3975579 [TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of vasodilators on pulmonary hypertension in decompensated chronic obstructive pulmonary disease. Cerdá E; Esteban A; de la Cal MA; Fernández A; García A Crit Care Med; 1985 Apr; 13(4):221-3. PubMed ID: 3979067 [TBL] [Abstract][Full Text] [Related]
9. [Variable hemodynamic response to nifedipine in pulmonary hypertension secondary to chronic obstructive bronchopathy and pulmonary fibrosis]. Domenighetti G Schweiz Med Wochenschr; 1985 Sep; 115(39):1345-7. PubMed ID: 4071009 [TBL] [Abstract][Full Text] [Related]
10. Effects of captopril in patients with chronic obstructive pulmonary disease and secondary pulmonary hypertension. Patakas D; Georgopoulos D; Rodini H; Christaki P Postgrad Med J; 1988 Mar; 64(749):193-5. PubMed ID: 3050941 [TBL] [Abstract][Full Text] [Related]
11. [The effects of diltiazem on pulmonary hemodynamics and oxygenation in copd induced pulmonary hypertension]. Fang B; Wang C; Dai H Zhonghua Yi Xue Za Zhi; 1998 Oct; 78(10):779-81. PubMed ID: 11038835 [TBL] [Abstract][Full Text] [Related]
12. Hemodynamic effects of a single dose of dopamine and L-dopa in pulmonary hypertension secondary to chronic obstructive lung disease. Philip-Joet F; Saadjian A; Vestri R; Tran Guyen A; Arnaud A Respiration; 1988; 53(3):146-52. PubMed ID: 3420304 [TBL] [Abstract][Full Text] [Related]
13. Inhaled nitric oxide does not improve cardiac or pulmonary function in patients with an exacerbation of chronic obstructive pulmonary disease. Baigorri F; Joseph D; Artigas A; Blanch L Crit Care Med; 1999 Oct; 27(10):2153-8. PubMed ID: 10548198 [TBL] [Abstract][Full Text] [Related]
14. The effects of flosequinan on hemodynamics and oxygen delivery in cor pulmonale. Elborn JS; Richardson G; Murphy P; MacMahon J Chest; 1992 Oct; 102(4):1155-60. PubMed ID: 1395760 [TBL] [Abstract][Full Text] [Related]
15. Effects of isosorbide dinitrate on pulmonary hypertension in chronic obstructive pulmonary disease. Danahy DT; Tobis JM; Aronow WS; Chetty K; Glauser F Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):541-8. PubMed ID: 373940 [TBL] [Abstract][Full Text] [Related]
16. Haemodynamic effects of ketanserin either alone or with oxygen in COPD patients with secondary pulmonary hypertension. Domenighetti G; Leuenberger P; Feihl F Monaldi Arch Chest Dis; 1997 Oct; 52(5):429-33. PubMed ID: 9510660 [TBL] [Abstract][Full Text] [Related]
17. [Pharmacologic effects of peripheral vasodilators in patients with secondary pulmonary hypertension]. Kukes VG; Tsoĭ AN; Abrosimov AG; Nasyrov ShN; Belov AM Klin Med (Mosk); 1989 May; 67(5):52-6. PubMed ID: 2671486 [TBL] [Abstract][Full Text] [Related]
18. Captopril effects on pulmonary and systemic hemodynamics in chronic cor pulmonale. Zieliński J; Hawrylkiewicz I; Górecka D; Gluskowski J; Kościńska M Chest; 1986 Oct; 90(4):562-5. PubMed ID: 3530649 [TBL] [Abstract][Full Text] [Related]
19. Hypoxic pulmonary hypertension: haemodynamic changes after oxygen and various vasodilators in the same patient at different time periods. Král H; Hamet A; Cernohorský D; Stásek J; Tilser P Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1993; 36(4-5):317-24. PubMed ID: 8599074 [TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery. Anand IS; Chandrashekhar Y; Ferrari R; Sarma R; Guleria R; Jindal SK; Wahi PL; Poole-Wilson PA; Harris P Circulation; 1992 Jul; 86(1):12-21. PubMed ID: 1617764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]